<table name="logo_release" border="0" cellspacing="10" cellpadding="5" align="right"> <tbody> <tr> <td><img src="https://mma.prnasia.com/media2/2044449/Croma_Pharma_Logo.jpg?p=medium600" border="0" alt="" title="logo" hspace="0" vspace="0" width="118" /></td> </tr> </tbody> </table> VIENNA, March 30, 2023 /PRNewswire/ -- Croma (Croma-Pharma&reg; GmbH) is a global player and challenger in the dynamically growing, minimally invasive aesthetics market and a leading manufacturer of premium quality hyaluronic acid (HA) syringes. With the launch of PhilArt, a complete series of injectable skin boosters, Croma is now further broadening its already comprehensive portfolio. Skin boosters are an important pillar of a minimally invasive aesthetics portfolio, next to HA fillers, botulinum toxin and PDO threads, allowing for combination therapies and a full-face approach. <a href="https://at.croma.at/assets/2303-PhilArt-Business-EN-FNL.pdf" target="_blank" rel="nofollow">Read More</a> Contact: Uschi Mayer External Communications &amp; PR CROMA-PHARMA GmbH Cromazeile 2, A-2100 Leobendorf, Austria M.: +43 676 84 68 68&nbsp;966 E: <a href="uschi.mayer@croma.at" target="_blank" rel="nofollow">uschi.mayer@croma.at</a> Logo:&nbsp;<a href="https://mma.prnasia.com/media2/2044449/Croma_Pharma_Logo.jpg?p=medium600" target="_blank" rel="nofollow">https://mma.prnasia.com/media2/2044449/Croma_Pharma_Logo.jpg?p=medium600</a>

PR Newswire Asia


						 			 VIENNA, March 30, 2023 /PRNewswire/ -- Croma (Croma-Pharma&reg; GmbH) is a global player and challenger in the dynamically growing, minimally invasive aesthetics market and a leading manufacturer of premium quality hyaluronic acid (HA) syringes. With the launch of PhilArt, a complete series of injectable skin boosters, Croma is now further broadening its already comprehensive portfolio. Skin boosters are...

Croma-Pharma: Further strengthening its portfolio with PhilArt biostimulators